DLH Reports Fourth Quarter Fiscal Year 2016 Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DLH Reports Fourth Quarter Fiscal Year 2016 Results

Completes Transformational Year with Growth on Track

ATLANTA, Dec. 08, 2016 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC ) , a leading provider of innovative healthcare services and solutions to federal agencies, today announced financial results for the fourth quarter ended September 30, 2016. 

Fourth Quarter and Full Year Highlights

  • Acquisition of Danya in 2016 – and integration with existing capabilities for healthcare management – position Company for stronger growth and improved operating performance going forward
  • Full year revenue of $85.6 million, versus $65.3 million in fiscal 2015 
  • Fourth quarter revenue of $27 million – up 60% over the fourth quarter of 2015 (including 4.4% organic growth)
  • Fourth quarter gross margin of 23.0% – an improvement of 310 basis points year-over-year
  • Fourth quarter diluted earnings per share of $0.20 on net income of $2.4 million for the quarter
  • Senior debt reduced to $23.4 million (versus $30.0 million on closing of Danya transaction)

Management Discussion

“As we turn the corner on fiscal 2016, it’s gratifying to look back and see what we’ve accomplished in a relatively short period of time,” stated DLH President and Chief Executive Officer Zach Parker. “Bolstered by the acquisition and integration of Danya, as well as subsequent actions taken to pay down debt, we’ve positioned the Company for stronger returns going forward. The fourth quarter was indicative of our achievements this year as a whole, with gross margins up 310 basis points and solid organic revenue growth. Income from operations also improved significantly for the quarter and for the year, notwithstanding the impact of non-cash amortization of intangible assets acquired in the Danya transaction.  Looking ahead, we see the potential for higher top line expansion if the new administration takes a more active role in outsourcing services, strengthening veterans’ healthcare, and driving IT modernization. We believe DLH is uniquely qualified to offer federal agencies the best in telehealth and data-driven healthcare management, and we look forward to the challenges - and opportunities - that fiscal 2017 will bring.”

Results for Three Months Ended September 30, 2016

Revenue for the fourth quarter of fiscal 2016 was $27.1 million, an increase of $10.1 million, or 59.6%, over the prior-year fourth quarter. This top line growth was primarily due to the acquisition of Danya on May 3, 2016 and the expansion of services on existing contract vehicles.

Gross margin of $6.2 million increased by $2.8 million, or 84.0%, over the fourth quarter of fiscal 2015. As a percent of revenue, the Company's gross margin was 23.0%, an increase of 310 basis points versus the prior-year period. The higher gross margin reflects the contribution from Danya, more complex contracts, and better contract management. The Company continues to focus on internal productivity measures to control costs and improve operating results.

General and Administrative ("G&A") expenses were $4.1 million, an increase of $1.7 million, or 70.2%, over the prior year fourth quarter. As a percent of revenue, G&A expenses were 15.2%, versus 14.2% in fiscal 2015. This increase was principally due to the addition of Danya as well as incremental program and operational resources required to manage and grow DLH’s business.

Income from operations rose nearly $0.4 million year-over-year to approximately $1.3 million. The increase in operating income reflects the improved gross margin of $2.8 million, partially offset by increased expenses of approximately $1.7 million as described above. In addition, current year operating income includes the $0.7 million of non-cash amortization of acquired intangibles from the May 2016 Danya transaction.

Income before taxes was approximately $0.8 million, a decrease of approximately $1.6 million versus the prior-year period, which benefited from the $1.5 million favorable closure of a legacy payroll tax issue. In addition, current year results reflect an improvement in income from operations, offset by increased interest expense of $0.5 million.

The Company realized an income tax benefit, net, of $1.6 million in the fourth quarter of 2016 compared to $5.8 million in 2015. These tax benefits reflect the release of a portion of DLH’s valuation allowance in connection with its deferred tax assets that are expected to be realized in future years.  The majority of this benefit was recorded in fiscal 2014 and 2015, with a smaller, residual adjustment in fiscal 2016.

Net income for the fourth quarter of 2016 was approximately $2.4 million, or $0.20 per diluted share, versus $8.2 million, or $0.82 per diluted share in the prior-year period. The decrease of approximately $5.9 million, or $0.62 per diluted share, was attributable principally to a $4.2 million decrease in the Company's tax benefit and a prior-year $1.5 million favorable impact from the closure of a legacy payroll tax issue.

On a non-GAAP basis, Earnings Before Interest Tax Depreciation and Amortization (“EBITDA”) adjusted for other items (“Adjusted EBITDA”) for the three months ended September 30, 2016 was approximately $2.2 million, an improvement of approximately $1.2 million, or 113.5% over the prior year three-month period.

Results for Year Ended September 30, 2016

DLH posted revenue for the full year ended September 30, 2016 of $85.6 million, an increase of $20.3 million or 31.0% over the prior year period. This increase was primarily due to the acquisition of Danya on May 3, 2016 and from the expansion of services on existing contract vehicles.

Gross margin was approximately $17.8 million, an increase of approximately $6.1 million, or 52.5%, over the prior fiscal year on higher revenue and improved contract performance. As a percent of revenue, the Company's gross margin was 20.8%, representing an increase of 290 basis points over fiscal 2015. The higher gross margin was primarily due to the impact from Danya, more complex contracts, and effective contract management.

G&A expenses were approximately $12.5 million, up $3.4 million, or 37.0%, versus fiscal 2015. As a percent of revenue, G&A expenses were 14.6%, as compared to 14.0% last year, reflecting the addition of Danya as well as incremental program and operational resources required to manage and grow the Company’s business. 

Income from operations for the year ended September 30, 2016 was approximately $4.1 million, an increase of approximately $1.6 million versus fiscal 2015.  The improvement was due principally to the contribution from Danya and expansion on legacy programs, which resulted in the aforementioned improved gross margin of $6.1 million, partially offset by higher expenses of $3.4 million as described above.  In addition, current year operating income includes $1.1 million of non-cash amortization of acquired intangibles from the May 2016 Danya transaction.

Income before taxes for the fiscal year ended September 30, 2016 was approximately $2.4 million, compared to $3.2 million for fiscal 2015.  The $0.8 million decrease was primarily due to a $0.8 million prior-year net favorable adjustment to other income, $0.8 million of acquisition expense and $0.8 million of higher interest expense related to the Danya acquisition, partially offset by $1.6 million of additional operating income in fiscal 2016.

The Company realized an income tax benefit, net, of approximately $0.9 million in fiscal 2016 compared to $5.5 million in fiscal 2015. These tax benefits reflect the release of a portion of DLH’s valuation allowance in connection with its deferred tax assets that are expected to be realized in future years. The majority of this benefit was recorded in fiscal 2014 and 2015, with a smaller, residual adjustment in fiscal 2016.

Net income for the year ended September 30, 2016 was approximately $3.4 million, or $0.30 per diluted share, compared to approximately $8.7 million, or $0.87 per diluted share, for fiscal 2015. The decrease year-over-year was primarily attributable to a $4.6 million decrease in the realized tax benefit and $2.4 million of additional "other" expenses, partially offset by $1.6 million of higher operating income.

Adjusted EBITDA for the year ended September 30, 2016 was approximately $5.8 million, an improvement of approximately $2.7 million, or 90.6%, over the prior year three-month period.  Growth was attributable to increased revenue and gross margin as described above.

Balance Sheet

Cash as of September 30, 2016 was $3.4 million, and the Company’s senior debt was $23.4 million (versus $30.0 million on closing of the Danya transaction).  During the quarter, subordinated debt of $2.5 million was extinguished using proceeds from a rights offering that closed in September 2016. Regarding cash flow, for the fiscal year ended September 30, 2016, cash provided by operating activities was 6.0 million.   

Given its expanding business base, the Company now expects to fully utilize its $36.0 million of federal net operating loss carryforwards. Accordingly, the Company does not anticipate being required to outlay significant cash for tax payments in the near future.

Non-GAAP Financial Measures

The Company believes that providing Income from Operations per share will be useful to investors in comparing year over year operating results for 2016 compared to 2015.  Income from Operations per share excludes the impact of other income (expense) and income tax benefits, which varied significantly from 2015 to 2016, independent of operating results.  By providing this non-GAAP measure, we believe that an investor can more easily compare year over year performance.

Reconciliation of GAAP earnings per share to Income from Operations per share, a non-GAAP measure:

(Amounts in Thousands)   Three Months Ended   Twelve Months Ended
    September 30,   September 30,
    2016   2015   Change   2016   2015   Change
Income from operations   $ 1,325     $ 958     $ 367     $ 4,064     $ 2,496     $ 1,568  
Other income (expense), net   (542 )   1,467     (2,009 )   (1,618 )   744     (2,362 )
Income before income taxes   783     2,425     (1,642 )   2,446     3,240     (794 )
Income tax expense (benefit), net   (1,604 )   (5,814 )   4,210     (938 )   (5,488 )   4,550  
Net income   $ 2,387     $ 8,239     $ (5,852 )   $ 3,384     $ 8,728     $ (5,344 )
                         
Weighted-average outstanding shares fully diluted   11,821     10,090     1,731     11,220     10,039     1,181  
                         
Net income per fully diluted share   $ 0.20     $ 0.82     $ (0.62 )   $ 0.30     $ 0.87     $ (0.57 )
Income tax expense (benefit), net   $ (0.14 )   $ (0.58 )   $ 0.44     $ (0.08 )   $ (0.55 )   $ 0.47  
Income before taxes   $ 0.06     $ 0.24     $ (0.18 )   $ 0.22     $ 0.32     $ (0.10 )
Other income (expense), net   $ 0.05     $ (0.15 )   $ 0.20     $ 0.14     $ (0.07 )   $ 0.21  
Income from operations per fully diluted share   $ 0.11     $ 0.09     $ 0.02     $ 0.36     $ 0.25     $ 0.11  

The Company uses Earnings Before Interest Tax Depreciation and Amortization (“EBITDA”) adjusted for other items (“Adjusted EBITDA”) as a supplemental non-GAAP measures of our performance. DLH defines Adjusted EBITDA as net income adjusted to exclude (i) interest and other expenses, including acquisition expenses, net, (ii) provision for or benefit from income taxes, if any, (iii) depreciation and amortization, and (iv) G&A expenses - equity grants.

This non-GAAP measure of our performance is used by management to conduct and evaluate its business during its regular review of operating results for the periods presented. Management and the Company’s Board utilize these non-GAAP measures to make decisions about the use of the Company’s resources, analyze performance between periods, develop internal projections and measure management performance. DLH believes that these non-GAAP measures are useful to investors in evaluating the Company’s ongoing operating and financial results and understanding how such results compare with the Company’s historical performance. By providing this non-GAAP measures as a supplement to GAAP information, DLH believes it enhances investors’ understanding of its business and results of operations.

Reconciliation of GAAP net income to adjusted EBITDA, a non-GAAP measure:

(Amounts in Thousands)   Three Months Ended   Twelve Months Ended
    September 30,   September 30,
    2016   2015   Change   2016   2015   Change
Net income   $ 2,387     $ 8,239     $ (5,852 )   $ 3,384     $ 8,728     $ (5,344 )
(i) Interest and other (income) expense (net):                        
(i)(a) Interest and other expense   542     (1,467 )   2,009     823     (744 )   1,567  
(i)(b) Acquisition expenses   —     —     —     795     —     795  
(ii) Provision (benefit) for taxes   (1,604 )   (5,814 )   4,210     (938 )   (5,488 )   4,550  
(iii) Depreciation and amortization   788     10     778     1,244     55     1,189  
(iv) G&A expenses - equity grants   82     60     22     466     479     (13 )
Adjusted EBITDA   $ 2,195     $ 1,028     $ 1,167     $ 5,774     $ 3,030     $ 2,744  
                         
Weighted-average outstanding shares fully diluted   11,821     10,090     1,731     11,220     10,039     1,181  

During the 2016 fiscal year, DLH acquired Danya International, LLC. The Company believes that it is helpful for investors to be able to evaluate the revenue performance of DLH’s underlying business excluding the impact of acquisitions. Therefore, the Company provides organic revenue growth as a non-GAAP measure to support this objective.  To calculate organic revenue growth, the Company compares current year revenue, less revenue from acquisitions, to prior year revenue.  Fiscal 2016 organic revenue growth was 4.4% for the quarter and 5.4% for the year compared to the prior year.

Conference Call and Webcast Details

DLH management will discuss fourth quarter results in a conference call beginning at 11:00 AM Eastern Time on Thursday, December 8, 2016 during which members of senior management will make a brief presentation focused on fourth quarter results and operating trends. A question-and-answer session will follow. 

Interested parties may listen to the conference call by dialing (844) 244-5605 and providing the operator with the conference ID 92586896.  Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.  A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing (855) 859-2056 and entering the conference ID 92586896.

About DLH

DLH (NASDAQ: DLHC ) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The Company's core competencies include assessment & compliance monitoring, business process outsourcing, health IT systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has over 1,400 employees working in over 30 locations throughout the country. For more information, visit the corporate web site at www.dlhcorp.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that are not statements of historical fact (including without limitation statements to the effect that the Company or its management "believes", "expects", "anticipates", "plans", “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH`s actual results to differ materially from those indicated by the forward-looking statements. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2016. The forward-looking statements contained in this press release are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.

TABLES TO FOLLOW

DLH HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands except per share amounts)
 
         
    Three Months Ended   Year Ended
    September 30,   September 30,
    2016   2015   2016   2015
Revenue   $ 27,120     $ 16,989     $ 85,602     $ 65,346  
Direct expenses   20,891     13,603     67,776     53,658  
Gross margin   6,229     3,386     17,826     11,688  
General and administrative expenses   4,116     2,418     12,518     9,137  
Depreciation and amortization   788     10     1,244     55  
Income from operations   1,325     958     4,064     2,496  
Other income (expense), net   (542 )   1,467     (1,618 )   744  
Income before income taxes   783     2,425     2,446     3,240  
Income tax expense (benefit), net   (1,604 )   (5,814 )   (938 )   (5,488 )
Net income   $ 2,387     $ 8,239     $ 3,384     $ 8,728  
                 
Earnings per share - basic   $ 0.23     $ 0.86     $ 0.34     $ 0.91  
Earnings per share - diluted   $ 0.20     $ 0.82     $ 0.30     $ 0.87  
                 
Weighted average common shares outstanding                
Basic   10,428     9,551     9,966     9,573  
Diluted   11,821     10,090     11,220     10,039  
DLH HOLDINGS CORP. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Amounts in thousands except par value of shares)
         
    September 30,  2016   September 30,  2015
ASSETS        
Current assets:        
Cash and cash equivalents   $ 3,427     $ 5,558  
Accounts receivable, net   6,637     3,286  
Deferred taxes, net   —     982  
Other current assets   542     429  
Total current assets   10,606     10,255  
Equipment and improvements, net   644     336  
Deferred taxes, net   11,415     9,325  
Goodwill and other intangible assets, net   42,304     8,595  
Other long-term assets   105     113  
Total assets   $ 65,074     $ 28,624  
LIABILITIES AND SHAREHOLDERS’ EQUITY        
Current liabilities:        
Debt obligations - current   $ 3,560     $ —  
Derivative financial instruments, at fair value   $ 204     $ —  
Accrued payroll   $ 3,616     $ 2,795  
Accounts payable, accrued expenses, and other current liabilities   7,136     2,851  
Total current liabilities   14,516     5,646  
Total long term liabilities   18,782     109  
Total liabilities   33,298     5,755  
Commitments and contingencies        
Shareholders' equity:        
Preferred stock, $.10 par value; authorized 5,000 shares, none issued and outstanding   —     —  
Common stock, $.001 par value; authorized 40,000 shares; issued and outstanding 11,148 at September 30, 2016 and 9,551 at September 30, 2015   11     10  
Additional paid-in capital   81,897     76,375  
Accumulated deficit   (50,132 )   (53,516 )
Total shareholders’ equity   31,776     22,869  
Total liabilities and shareholders' equity   $ 65,074     $ 28,624  

CONTACTS: COMMUNICATIONS Contact: Tiffany McCall Phone: 404-334-6000 Email: tiffany.mccall@dlhcorp.com INVESTOR RELATIONS Contact: Chris Witty Phone: 646-438-9385 Email: cwitty@darrowir.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bernard Lancaster Steps Up as Mammoth's New President

Updated Category News Views 143

A New Era Under Bernard Lancaster at Mammoth Change is in the air for Mammoth Energy Services, as Bernard “Bernie” Lancaster takes the helm as President. His promotion on November 9, 2026, might not send shockwaves through Wall Street right away, but anyone holding an interest in NASDAQ:TUSK should take note. Lancaster's appointment is the kind of decision that...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 62

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Stent or Meds? Long-Term Study Questions Benefits

Updated Category News Views 101

The Long Game in Cardiology There's this long-standing debate in cardiology about whether sticking a metal stent in an artery actually prevents heart attacks or just looks impressive. Well, after chewing on 25 years of data from the COURAGE trial, CU Anschutz researchers led by Dr. Neel Butala have thrown a curveball — these stents might not be as life-saving as many...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 107

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
Diwali Celebration in Chicago Honors Indian Community

Updated Category News Views 142

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Continue Reading
Sports Clock Radio: A Game Time Enthusiast's Dream

Updated Category News Views 45

A New Gadget for the Diehard Fan Fanatics, gather 'round. There's an innovation rolling out that's looking to marry the good old alarm clock radio with the rush of game day fever! Over in Pittsburgh, an inventor's cooking up something that every loyal sports fan might soon find irresistible—a Sports Clock Radio, bringing the stadium experience to your living room or...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 40

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 51

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

Updated Category News Views 157

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Continue Reading
Cuisine.K Brings Korean Seafood to Seattle Spotlight

Updated Category News Views 93

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Continue Reading

Top 5 Most Recently Viewed Articles

Avita Medical's Recell Go Mini FDA Approval Boosts Stock

Updated Category News Views 190

Avita Medical’s Recell Go Mini Secures FDA Approval Avita Medical (NASDAQ: RCEL) has recently achieved a significant milestone as its Recell Go mini received approval from the US Food and Drug Administration (FDA). This news sparked a remarkable surge of over 6% in the stock during post-market trading. This approval represents a key advancement for Avita Medical and its...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 444

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Driving Engagement in Diabetes Management Through TV Ads

Updated Category News Views 326

Unlocking Consumer Engagement in Diabetes Advertising As the landscape of diabetes management continues to evolve, the synergy between innovative treatments and effective advertising strategies is crucial. Recent analysis highlights how companies like Dexcom, Ozempic, and Mounjaro are capturing consumer attention through targeted covrergent TV advertising methods. Key...

Continue Reading
Analyzing D.R. Horton's Increasing Short Interest Dynamics

Updated Category News Views 99

Understanding D.R. Horton's Short Interest Trends D.R. Horton's DHI short interest has recently noted a significant increase, currently standing at 7.22 million shares sold short. This accounts for 2.89% of the company’s available trading shares. Traders should take note that it would take approximately 1.95 days, based on current trading volume, to cover these short...

Continue Reading
Tint World® Celebrates Franchise Success and Recognition

Updated Category News Views 172

Celebrating Franchise Success at the Tint World® Convention Tint World® Automotive Styling Centers™, a prominent leader in auto accessories and window tinting franchises, recently gathered franchise owners from around the globe to celebrate achievements and recognize the burgeoning members of its prestigious Million Dollar Club at their annual International Franchise...

Continue Reading